These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 14732793)
1. Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia. Kolsuz M; Erginel S; Alataş O; Alataş F; Metintaş M; Uçgun I; Harmanci E; Colak O Respiration; 2003; 70(6):615-22. PubMed ID: 14732793 [TBL] [Abstract][Full Text] [Related]
2. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Montón C; Torres A; El-Ebiary M; Filella X; Xaubet A; de la Bellacasa JP Crit Care Med; 1999 Sep; 27(9):1745-53. PubMed ID: 10507593 [TBL] [Abstract][Full Text] [Related]
3. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Dehoux MS; Boutten A; Ostinelli J; Seta N; Dombret MC; Crestani B; Deschenes M; Trouillet JL; Aubier M Am J Respir Crit Care Med; 1994 Sep; 150(3):710-6. PubMed ID: 8087341 [TBL] [Abstract][Full Text] [Related]
4. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia. Lee YL; Chen W; Chen LY; Chen CH; Lin YC; Liang SJ; Shih CM J Crit Care; 2010 Mar; 25(1):176.e7-13. PubMed ID: 19592208 [TBL] [Abstract][Full Text] [Related]
5. Expression of pro-inflammatory cytokines by flow-sorted alveolar macrophages in severe pneumonia. Maus U; Rosseau S; Knies U; Seeger W; Lohmeyer J Eur Respir J; 1998 Mar; 11(3):534-41. PubMed ID: 9596098 [TBL] [Abstract][Full Text] [Related]
6. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Schütte H; Lohmeyer J; Rosseau S; Ziegler S; Siebert C; Kielisch H; Pralle H; Grimminger F; Morr H; Seeger W Eur Respir J; 1996 Sep; 9(9):1858-67. PubMed ID: 8880103 [TBL] [Abstract][Full Text] [Related]
7. Role of cytokine profile in the differential diagnosis between acute lung rejection and pulmonary infections after lung transplantation†. Patella M; Anile M; Del Porto P; Diso D; Pecoraro Y; Onorati I; Mantovani S; De Giacomo T; Ascenzioni F; Rendina EA; Venuta F Eur J Cardiothorac Surg; 2015 Jun; 47(6):1031-6. PubMed ID: 25344921 [TBL] [Abstract][Full Text] [Related]
8. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Mejias A; Somers C; Chavez-Bueno S; McCracken GH; Hardy RD Infect Immun; 2007 Jan; 75(1):236-42. PubMed ID: 17074851 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of the characteristics of cellular immune function and its prognostic risk factors in patients with community-acquired pneumonia]. Ding T; Gao L; Zheng L; Ye J; Zhao H Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):684-688. PubMed ID: 31315723 [TBL] [Abstract][Full Text] [Related]
10. Expression Levels of Interferon Regulatory Factor 5 (IRF5) and Related Inflammatory Cytokines Associated with Severity, Prognosis, and Causative Pathogen in Patients with Community-Acquired Pneumonia. Wang X; Guo J; Wang Y; Xiao Y; Wang L; Hua S Med Sci Monit; 2018 May; 24():3620-3630. PubMed ID: 29847542 [TBL] [Abstract][Full Text] [Related]
11. Temperature and serum proinflammatory cytokine changes in patients with NSCLC after BAL. Georgiades G; Myrianthefs P; Venetsanou K; Kythreoti A; Kyroudi A; Kittas C; Baltopoulos G Lung; 2003; 181(1):35-47. PubMed ID: 12879338 [TBL] [Abstract][Full Text] [Related]
12. T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia. Paats MS; Bergen IM; Hanselaar WE; van Zoelen EC; Verbrugh HA; Hoogsteden HC; van den Blink B; Hendriks RW; van der Eerden MM Thorax; 2013 May; 68(5):468-74. PubMed ID: 23315492 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Meduri GU; Kohler G; Headley S; Tolley E; Stentz F; Postlethwaite A Chest; 1995 Nov; 108(5):1303-14. PubMed ID: 7587434 [TBL] [Abstract][Full Text] [Related]
14. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Antunes G; Evans SA; Lordan JL; Frew AJ Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694 [TBL] [Abstract][Full Text] [Related]
15. Etiology and cytokine expression in patients requiring mechanical ventilation due to severe community-acquired pneumonia. Wu CL; Chan MC; Chang GC; Lee YL; Chin CS; Chang KM; Hsu JY J Formos Med Assoc; 2006 Jan; 105(1):49-55. PubMed ID: 16440070 [TBL] [Abstract][Full Text] [Related]
16. Cytokine levels in bronchoalveolar lavage and serum in 3 patients with 2009 Influenza A(H1N1)v severe pneumonia. Estella A J Infect Dev Ctries; 2011 Jul; 5(7):540-3. PubMed ID: 21795823 [TBL] [Abstract][Full Text] [Related]
17. Cytokine profiles of bronchoalveolar lavage fluid in patients with pneumocystis pneumonia. Tasaka S; Kobayashi S; Kamata H; Kimizuka Y; Fujiwara H; Funatsu Y; Mizoguchi K; Ishii M; Takeuchi T; Hasegawa N Microbiol Immunol; 2010 Jul; 54(7):425-33. PubMed ID: 20618689 [TBL] [Abstract][Full Text] [Related]
18. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Glynn P; Coakley R; Kilgallen I; Murphy N; O'Neill S Thorax; 1999 Jan; 54(1):51-5. PubMed ID: 10343632 [TBL] [Abstract][Full Text] [Related]
19. Patterns of cytokine expression in community-acquired pneumonia. Puren AJ; Feldman C; Savage N; Becker PJ; Smith C Chest; 1995 May; 107(5):1342-9. PubMed ID: 7750329 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of interleukin-6 in bronchoalveolar lavage fluid and serum of patients with lung cancer. Dowlati A; Levitan N; Remick SC J Lab Clin Med; 1999 Oct; 134(4):405-9. PubMed ID: 10521088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]